Donald Lloyd-Jones, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Lloyd-Jones’ research interests include the study of the mechanisms and life course of cardiovascular health and healthy aging, and cardiovascular disease epidemiology, risk estimation and prevention. Other areas of interest include the use of novel biomarkers and imaging of subclinical atherosclerosis to improve prevention, and the epidemiology and outcomes of hypertension and dyslipidemia. His clinical and teaching interests lie in general cardiology, with a focus on prevention.

He also has been a national leader in public health and clinical approaches to promoting cardiovascular health and preventing cardiovascular diseases across the life course. He served as co-chair of the Risk Assessment Guidelines and a member of the Cholesterol Treatment Guidelines Panel for the 2013 ACC/AHA Guidelines for Cardiovascular Disease Risk Reduction; and was the lead member for risk assessment on the 2018 Cholesterol Guidelines Panel and the 2019 Primary Prevention Guidelines Panel. He has authored over 750 peer-reviewed scientific publications and has been a PI or co-investigator on more than 120 grants (the vast majority from NIH)

Publications

  • Published 3/5/2026

    Goldman N, Allen NB, Pratt B, Ning H, Schneper L, Lloyd-Jones D, Notterman D. Racial and ethnic variation in socioeconomic differentials in young adult cardiovascular health. Am J Epidemiol. 2026 Mar 05; 195(3):800-806. PMID: 40331753.

    Read at: PubMed

  • Published 2/12/2026

    Davis DN, Gajjar P, Xanthakis V, Lloyd-Jones D, Nayor M. Refined Heart Failure Stages Incorporating Cardiorespiratory Fitness Are Differentially Associated With Heart Failure Risk in the Community. J Am Heart Assoc. 2026 Feb 17; 15(4):e045791. PMID: 41676947.

    Read at: PubMed

  • Published 1/28/2026

    Freedman AA, Colangelo LA, Ning H, Borrowman JD, Lewis CE, Schreiner PJ, Khan SS, Lloyd-Jones DM. Sex Differences in Age of Onset of Premature Cardiovascular Disease and Subtypes: The Coronary Artery Risk Development in Young Adults Study. J Am Heart Assoc. 2026 Feb 03; 15(3):e044922. PMID: 41605575.

    Read at: PubMed

  • Published 11/25/2025

    Krishnan V, Huang X, Zhang S, Shah NS, Navar AM, Coresh J, Rangaswami J, Ho JE, Khera A, Blumenthal RS, Pencina M, Lloyd-Jones DM, Greenland P, Ndumele CE, Khan SS. Age and Sex-Specific Percentiles of 30-Year Cardiovascular Disease Risk Based on the PREVENT Equations. J Am Coll Cardiol. 2025 Nov 25; 86(21):2017-2027. PMID: 41260756.

    Read at: PubMed

  • Published 11/12/2025

    Chen Y, Zheng Y, Zhao L, Gao T, Qu Y, Carr JJ, Terry JG, Ning H, Kim K, Long MT, Zhang X, Wilkins JT, Chen A, Zhang K, Allen NB, Lloyd-Jones DM, Hou L, Zhang X. Cumulative lipid exposure in young adulthood and risk of midlife MASLD. JHEP Rep. 2026 Mar; 8(3):101679. PMID: 41659770.

    Read at: PubMed

View All 821 Publications:   View Full Profile in BUMC

Other Positions

  • Director of Framingham Center for Population and Prevention Science, Framingham Heart Study
    Boston University
  • Principal Investigator of the Framingham Heart Study, Framingham Heart Study
    Boston University
  • Chief of the section, Preventive Medicine
    Boston University

Websites

Education

  • Columbia University College of Physicians and Surgeons, MD
  • Harvard School of Public Health, MS
  • Swarthmore College, BA

View all profiles